Search results for " Population"

showing 10 items of 1682 documents

Blood, breast milk and urine: potential biomarkers of exposure and estimated daily intake of ochratoxin A: a review.

2015

The purposes of this review are to study potential biomarkers of exposure for ochratoxin A (OTA) in biological fluids (blood, urine and breast milk) for the period 2005-14, calculate the estimated daily intake (EDI) of OTA by using database consumption for the Spanish population, and, finally, to correlate OTA levels detected in blood and EDI values calculated from food products. The values of OTA detected in potential biomarkers of exposure for blood, breast milk and urine ranged from 0.15 to 18.0, from 0.002 to 13.1, and from 0.013 to 0.2 ng ml(-1), respectively. The calculated EDI for OTA in plasma ranged from 0.15 to 26 ng kg(-1) bw day(-1), higher than that obtained in urine (0.017-0.4…

Ochratoxin ADaily intakeHealth Toxicology and MutagenesisFood ContaminationUrineBreast milkToxicologyToxicologychemistry.chemical_compoundMedicineHumansFood scienceMycotoxinMilk HumanMolecular Structurebusiness.industryPublic Health Environmental and Occupational HealthGeneral ChemistryGeneral MedicineEnvironmental ExposureOchratoxinsSpanish populationchemistryPotential biomarkersFood productsbusinessBiomarkersFood ScienceFood additivescontaminants. Part A, Chemistry, analysis, control, exposurerisk assessment
researchProduct

Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey

2013

BackgroundBone metastasis represents an increasing clinical problem in advanced gastric cancer (GC) as disease-related survival improves. In literature, few data on the natural history of bone disease in GC are available.Patients and methodsData on clinicopathology, skeletal outcomes, skeletal-related events (SREs), and bone-directed therapies for 208 deceased GC patients with evidence of bone metastasis were statistically analyzed.ResultsMedian time to bone metastasis was 8 months (CI 95%, 6.125-9.875 months) considering all included patients. Median number of SREs/patient was one. Less than half of the patients (31%) experienced at least one and only 4 and 2% experienced at least two and …

OncologyAdultMalemedicine.medical_specialtyPathologyBone diseaseSettore MED/06 - Oncologia Medicamedicine.medical_treatmentScienceBone NeoplasmsMetastasisgastric cancer; bone metastasisStomach NeoplasmsInternal medicinemedicineHumansskeletal disease advanced hepatocellular carcinomaskeletal-related events bisphosphonateAdult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Patient Outcome Assessment; Population Surveillance; Prognosis; Retrospective Studies; Stomach NeoplasmsNeoplasm Metastasisbone metastasisAgedRetrospective StudiesMultidisciplinaryBone Density Conservation AgentsDiphosphonatesbusiness.industrygastric cancerQRBone metastasisCancerBone fractureMiddle Agedmedicine.diseasePrognosisRadiation therapyPatient Outcome AssessmentBone Density Conservation AgentsZoledronic acidPopulation SurveillanceMedicineFemalebusinessmedicine.drugResearch Article
researchProduct

Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in S…

2017

ABSTRACT While bivalent and quadrivalent HPV vaccines have been used for about 10 years, a nonavalent vaccine against HPV types 6/11/16/18/31/33/45/52 and 58 has been recently approved by FDA and EMA and is now commercially available. The objective of our study was to evaluate the potential impact of the nonavalent vaccine on HPV infection and related low- and high-grade squamous intraepithelial lesions (LSIL, HSIL), compared to the impact of the quadrivalent vaccine, in a female population living in Sicily (Italy). Low estimates of HPV vaccine impact were calculated as prevalence of HPV 6/11/16/18/31/33/45/52 and 58 genotypes, alone or in association, but excluding presence of other HPV ty…

OncologyAdultmedicine.medical_specialtyReferralGenotypeImmunologyUterine Cervical NeoplasmsHPV vaccinesCervix UteriHospital based study03 medical and health sciences0302 clinical medicineHuman Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18Internal medicinevaccineGenotypemedicinePrevalenceHumansImmunology and Allergy030212 general & internal medicinePapillomavirus VaccinesquadrivalentReferral and ConsultationSicilyFemale populationsquamous intraepithelial lesionGynecologyPharmacologyPotential impactHpv typesbusiness.industryPapillomavirus InfectionsHPV infectionsquamous intraepithelial lesionsvirus diseasesmedicine.diseaseUterine Cervical DysplasiaResearch Papersimpact estimateHPV infection; impact estimate; nonavalent; quadrivalent; squamous intraepithelial lesions; vaccine; Immunology and Allergy; Immunology; Pharmacology030220 oncology & carcinogenesisHPV infectionFemalebusinessnonavalent
researchProduct

The influence of socio-economic and surveillance characteristics on breast cancer survival: a French population-based study.

2008

International audience; Survival data on female invasive breast cancer with 9-year follow-up from five French cancer registries were analysed by logistic regression for prognostic factors of cancer stage. The Kaplan-Meier method and log-rank test were used to estimate and compare the overall survival probability at 5 and 7 years, and at the endpoint. The Cox regression model was used for multivariate analysis. County of residence, age group, occupational status, mammographic surveillance, gynaecological prevention consultations and the diagnosis mammography, whether within a screening framework or not, were independent prognostic factors of survival. Moreover, for the same age group, and on…

OncologyCancer ResearchEpidemiologyMESH : AgedMESH : Breast NeoplasmsLogistic regressionsurvival analysis0302 clinical medicineMESH: Aged 80 and overMESH : Population SurveillanceMESH : Socioeconomic FactorsMedicineMESH : Female030212 general & internal medicineAged 80 and overMESH: AgedMESH: Middle Agedmedicine.diagnostic_testCarcinoma Ductal Breast[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieMESH: European Continental Ancestry GroupMESH: Follow-Up StudiesMiddle AgedMESH : AdultMESH : Survival Rate3. Good healthSurvival RateOncology030220 oncology & carcinogenesisPopulation SurveillanceFemalemass screeningAdultmedicine.medical_specialtyMESH: Socioeconomic FactorsMESH: Survival RatemammographyMESH: MammographyBreast NeoplasmsWhite PeopleMESH: Population SurveillanceMESH : European Continental Ancestry Group03 medical and health sciencesBreast cancerbreast neoplasmInternal medicineMammographyHumansMESH : MammographyMESH : Middle AgedMESH: Mass ScreeningMESH : Aged 80 and overSurvival rateMass screeningSurvival analysisAgedGynecologyMESH : Mass ScreeningMESH: Humansbusiness.industryProportional hazards modelMESH : HumansMESH : Carcinoma Ductal BreastCancerMESH: AdultMESH : Follow-Up Studiesmedicine.diseaseMESH: Carcinoma Ductal BreastSocioeconomic Factors[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologiesocio-economic factors[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessMESH: FemaleMESH: Breast NeoplasmsFollow-Up Studies
researchProduct

Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology.

2021

Abstract The COVID-19 pandemic affected millions of people globally with lasting effects on society, patients, investigators and health institutions. Clinical trials, our best tool to improve cancer treatment for patients through testing the clinical value of a new treatment, have been affected by the pandemic. The pandemic footprint represents both a risk of compromising development of new therapies and an opportunity to elicit discussion over a portfolio of broader reforms, applicable irrespective of pandemics, in order to improve the design and implementation of clinical trials in oncology. The administrative load should be reduced, without affecting the quality of research and principle…

OncologyCancer ResearchTelemedicinemedicine.medical_specialtyOncologiamedia_common.quotation_subjectMedical Oncology:profesiones sanitarias::medicina::medicina interna::oncología médica [DISCIPLINAS Y OCUPACIONES]Quality of life (healthcare):características del estudio::estudio clínico::ensayo clínico [CARACTERÍSTICAS DE PUBLICACIONES]:Study Characteristics::Clinical Study::Clinical Trial [PUBLICATION CHARACTERISTICS]Internal medicinePandemic:virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES]medicinePandèmia de COVID-19 2020-HumansQuality (business):Health Occupations::Medicine::Internal Medicine::Medical Oncology [DISCIPLINES AND OCCUPATIONS]Pandemicsmedia_commonCOVID-19; Humans; Medical Oncology; Pandemics/prevention & control; SARS-CoV-2; TelemedicineSurrogate endpointSARS-CoV-2COVID-19:Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES]World populationTelemedicineClinical trialEditorialOncologyGood clinical practiceBusinessAssaigs clínicsESMO open
researchProduct

P-309 Correlation between baseline CEA levels and TNM stage at presentation in colorectal cancers in an Indian population

2020

OncologyCorrelationmedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineIndian populationHematologyStage (cooking)Presentation (obstetrics)businessBaseline (configuration management)Annals of Oncology
researchProduct

Clinical and molecular characteristics of the patients in the liquid biopsy study in mEGFR-NSCLC in a Spanish population (OPH-1).

2020

e21515 Background: The liquid biopsy (LB) is an important tool in the diagnostic and follow up of the patients with non-small cell lung cancer (NSCLC) and can provide big information about the mutational variability of the disease during of the treatment. Methods: We conducted a multicenter study with 200 patients with EGFR-mutated NSCLC, treated with first-line TKI therapy. We analyse the ctDNA by dPCR pre-treatment, at 8 weeks, at 7 months and at the progression of the disease (PD). Results: A total of 200 patients (60% women / 40% men) were included. The median of age was 68-year. The never smokers were 56% and 34% ex-smokers. 92% of the cases were adenocarcinomas. According to the stag…

OncologySpanish populationCancer Researchmedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineNon small cellLiquid biopsybusinessrespiratory tract diseasesJournal of Clinical Oncology
researchProduct

GRAPH-BASED RULES FOR XML DATA CONVERSION TO OWL ONTOLOGY

2010

International audience; The paper presents a flexible method to enrich and populate an existing OWL ontology from XML data based on graph-based rules. These rules are defined in order to populate automatically a new version of an OWL ontology. Today, most of data exchanged between information systems is done with the help of the XML document. Leading researches in the domain of database systems are moving to semantic model in order to store data and its semantics definition. This flexible method consists in populating an existing OWL ontology from XML data. In paper we present such a method based on the definition of a graph which represents rules that drive the populating process.

Ontolog population[INFO.INFO-OH] Computer Science [cs]/Other [cs.OH]ontology enrichment[INFO.INFO-OH]Computer Science [cs]/Other [cs.OH]XML dataComputingMethodologies_DOCUMENTANDTEXTPROCESSING[ INFO.INFO-OH ] Computer Science [cs]/Other [cs.OH]OWL ontologysemantic annotationRDF
researchProduct

Geometric Optimal Control of the Generalized Lotka-Volterra Model of the Intestinal Microbiome

2022

We introduce the theoretical framework from geometric optimal control for a control system modeled by the Generalized Lotka-Volterra (GLV) equation, motivated by restoring the gut microbiota infected by Clostridium difficile combining antibiotic treatment and fecal injection. We consider both permanent control and sampled-data control related to the medical protocols.

Optimal control in the permanent casebiomathematics and population dynamicssampled-data control[MATH.MATH-OC] Mathematics [math]/Optimization and Control [math.OC][MATH.MATH-OC]Mathematics [math]/Optimization and Control [math.OC]
researchProduct

Prevalence and characterization of maxillary sinus septa in a brazilian population

2019

Background The aim of this study was to assess the anatomic aspects of the maxillary sinus septa, by means of computed tomography images, in a Brazilian population. The results might be of clinical significance in sinus lift surgery planning. Material and methods In the study, 123 computed tomographs obtained from a private radiology clinic were used. They were analyzed by a single, trained and calibrated observer in order to evaluate the presence, quantity, localizations, dimensions, orientations and different characteristics in dentate, partially edentulous and completely edentulous individuals of the sinus septa. Results Of the individuals analyzed, 26% had a septum in the maxillary sinu…

OrthodonticsMaxillary sinusDentitionbusiness.industryResearchSinus liftMultislice computed tomographyAnatomic Variationmedicine.anatomical_structuremedicineBrazilian populationClinical significanceOral SurgerybusinessGeneral DentistrySinus (anatomy)UNESCO:CIENCIAS MÉDICAS
researchProduct